Attention deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterized by age-inappropriate symptoms of inattention, impulsivity and hyperactivity that persist into adulthood in the majority of the diagnosed children. Despite several risk factors during childhood predicting the persistence of ADHD symptoms into adulthood, the genetic architecture underlying the trajectory of ADHD over time is still unclear. We set out to study the contribution of common genetic variants to the risk for ADHD across the lifespan by conducting meta-analyses of genome-wide association studies on persistent ADHD in adults and ADHD in childhood separately and comparing the genetic background between them in a total sample of 17,149 cases and 32,411 controls. Our results show nine new independent genome-wide significant loci and support a shared contribution of common genetic variants to ADHD in children and adults. No subgroup heterogeneity was observed among children, while this group consists of future remitting and persistent individuals. We report similar patterns of genetic correlation of ADHD with other ADHD-related datasets and different traits and disorders among adults, children and when combining both groups. These findings confirm that persistent ADHD in adults is a neurodevelopmental disorder and extend the existing hypothesis of a shared genetic architecture underlying ADHD and different traits to a lifespan perspective.
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Attention deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder that severely impairs the daily functioning of patients due to age-inappropriate levels of impulsivity and hyperactivity, and/or difficulties in focusing attention. ADHD has a prevalence of 3.4% in childhood, and impairing symptoms persist into adulthood in around two-thirds of children with ADHD diagnosis, with an estimated adult prevalence around 3% 1, 2 .
ADHD is a multifactorial disorder with heritability averaging 76% throughout the lifespan [3] [4] [5] . There is consistent evidence that both common and rare variants make an important contribution to the risk for the disorder [6] [7] [8] [9] [10] [11] . Several genome-wide association studies (GWAS) and meta-analyses across those have been conducted 7 , but only the largest GWAS meta-analysis (GWAS-MA) performed to date, including 20,183 ADHD patients and 35,191 controls, reported genome-wide significant loci (N=12) 6 . This study concluded that common genetic variants (minor allele frequency, MAF, >0.01) account for 22% of the heritability of the disorder 6 and supported substantial genetic overlap between ADHD and other brain disorders and behavioral/cognitive traits 12 .
The presentation of ADHD symptoms changes from childhood to adulthood, with lower levels of hyperactivity in adulthood but a high risk for ongoing attention problems, disorganization, and emotional dysregulation 13, 14 . As in the general population, the pattern of psychiatric and somatic comorbid conditions in ADHD also changes substantially over time, with learning disabilities, oppositional defiant disorder, enuresis and conduct disorder being more prevalent in children, and substance use disorders, social phobia, insomnia, obesity, and mood disorders becoming more pronounced in adulthood 1, [15] [16] [17] [18] . In addition, persistent ADHD in adults is, compared to the general population (and to cases with remitting ADHD), associated with higher risk for a wide range of functional and social impairments, including unemployment, accidents and criminal behavior 7, [19] [20] [21] [22] [23] .
Several risk factors measured in childhood predict the persistence of ADHD symptoms into adulthood, such as the presence of comorbid disorders, the severity of ADHD symptoms, being exposed to psychosocial adversity as well as having a high polygenic risk score for childhood ADHD [24] [25] [26] [27] [28] . Twin studies suggest that both stable and dynamic genetic influences affect the persistence of ADHD symptoms 4, 5, 29, 30 . However, specific genetic factors differentiating childhood and persistent ADHD into adulthood are not well understood due to the lack of longitudinal studies. Since molecular gene-finding studies, including the most recent GWAS-MA of ADHD, have been performed in children and adults either separately or jointly 6, [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] , large-scale analyses comparing the genetic basis of children and adults with persistent ADHD are yet to be conducted.
Given this background, we set out to study the contribution of common genetic variants to the risk for ADHD from a lifespan perspective. We report, for the first time, a GWAS-MA on persistent ADHD in adults (according to DSM-IV/ICD-10 criteria), a GWAS-MA on ADHD in childhood (that may include remittent and persistent forms of the disorder), and the comparison of the genetic background of the two.
Results

GWAS meta-analysis of persistent ADHD in adults
The GWAS-MA of persistent ADHD in adults included six datasets from the International Multicentre persistent ADHD CollaboraTion (IMpACT) consortium, two datasets from the Psychiatric Genomics Consortium (PGC) and the subset of adults from the Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH) cohort included in Demontis and Walters et al. 6 (detailed information can be found in Supplementary Table 12 and in the Supplementary Material). In total, 22,406 individuals (6,532 adult ADHD cases and 15,874 controls) were included. The overall lambda (λ) value was 1.09 (λ1000= 1.01) and the linkage disequilibrium (LD) score regression ratio was 0.13, suggesting minimal population stratification or other systematic biases (Supplementary Figure 1A) . The proportion of heritability of persistent ADHD attributable to common single nucleotide polymorphisms (SNP-h 2 ) was 0.21 (SE=0.026), with a nominally significant enrichment in the heritability of variants located in conserved genomic regions (P=5.18E-03) and in the cell-specific histone mark H3K4me1 (P=3.17E-02) ( Supplementary   Figure 2A ). The gene-based analysis revealed six genes significantly associated with persistent ADHD, with ST3GAL3 being the most significant one (P=8.72E-07) ( Supplementary Table 1A ).
The single-marker analysis showed no variants exceeding genome-wide significance (P<5.00E-08), with the most significant signal being rs3923931 (P=1.69E-07) ( Figure 1A and Supplementary Table 2A ). Similarly, no significant gene sets were identified in the pathway analysis after correction for multiple comparisons ( Supplementary Table 3A [in excel]).
GWAS meta-analysis of ADHD in childhood
To compare the genetic background between persistent ADHD in adults and ADHD in childhood (that may include future remittent and persistent forms of the disorder), we conducted a GWAS-MA on children with ADHD in a total of 27,154 individuals (10,617 ADHD cases and 16,537 controls). The sample consisted of two datasets from Brazil and Spain, seven datasets from the PGC and the subset of children from the iPSYCH cohort included in Demontis and Walters et al. 6 (detailed information can be found in Supplementary Table 12 and in the Supplementary Material). We found no evidence of genomic inflation and minimal population stratification (λ=1. 12 and λ1000=1.01, LD score regression ratio=0.13) (Supplementary Figure 1B) . The SNP-h 2 for ADHD in childhood was 0.20 (SE=0.023), with a significant enrichment in the heritability of variants located in conserved genomic regions after Bonferroni correction (P=1.21E-06) (Supplementary Figure 2B) . The gene-based analysis highlighted a significant association between FEZF1 and ADHD in childhood (P=5.42E-07) ( Supplementary Table 1B ). No single genetic variant exceeded genome-wide significance (P<5.00E-08), with the top signal being in rs55686778 (P=1.67E-07) ( Figure 1B and Supplementary Table 2B ), and no significant gene sets were identified in the pathway analysis after correction for multiple comparisons ( Supplementary   Table 3B [in excel]).
Comparison of the genetic background of persistent ADHD in adults and ADHD in childhood
We found a strong and significant genetic correlation between persistent ADHD in adults and ADHD in childhood (rg=0.81, SE=0.09, P=2.13E-21). Sign test results provided evidence of a consistent direction of effect of genetic variants associated with ADHD in children in persistent ADHD and vice-versa (P=6.60E-04 and P=4.47E-03, respectively for variants with P<5.00E-05 in either dataset) (Supplementary Table 4 ). In addition, Polygenic Risk Score (PRS) analyses showed that childhood ADHD PRSs were associated with persistent ADHD at different predefined P-value thresholds, with the P=0.40 threshold explaining the most variance (P=1.20E-27 and R 2 =0.0041) ( Figure 2A ). The quintiles of the PRS built using this threshold showed the expected trend of higher ADHD risk for individuals in higher quintiles ( Figure 2B , Supplementary Table 5 ).
We tested whether the genetic correlation between persistent ADHD and ADHD in childhood was driven by a subset of children enriched for persistent ADHD-associated alleles using the Breaking Up Heterogeneous Mixture Based On Cross-locus correlations (BUHMBOX) analysis. We found no evidence of genetic heterogeneity in children, supporting that the sharing of persistent ADHDassociated alleles between children and adults was driven by the whole group of children, with a statistical power >98% and assuming 65% persistence (Supplementary Table 6 ).
Meta-analysis of GWAS on ADHD across the lifespan
Given the strong genetic correlation between persistent ADHD in adults and ADHD in children, we performed a GWAS-MA of ADHD across the lifespan including all datasets available (nine GWAS of persistent ADHD in adults and 10 GWAS of ADHD in childhood). In total, we included 49,560 individuals (17,149 ADHD cases and 32,411 controls), and no evidence of genomic inflation nor population stratification was found (λ=1. 18 and λ1000=1 .01, LD score regression ratio=0.14) (Supplementary Figure 1C) . The SNP-h 2 for ADHD across the lifespan was 0.19 (SE=0.01), and a significant enrichment in the heritability of findings in conserved genomic regions after Bonferroni correction (P=1.53E-06) was observed (Supplementary Figure 2C ). We identified four genome-wide significant variants ( Figure 1C , Figure 3 , Table 1A and Supplementary Figure 3 ) and nine genes (FEZF1, DUSP6, ST3GAL3, SEMA6D, KDM4A, C2orf82, GIGYF2, AMN and FBXL17) significantly associated with ADHD across the lifespan (Table 1B) . The most significantly associated locus was on chromosome 6 (index variant rs183882582-T, OR=1.43 (95% CI 1.26-1.60), P=1.57E-08), followed by loci on chromosome 7 (index variant rs3958046), chromosome 4 (index variant rs200721207) and chromosome 3 (index variant rs1920644) (Table 1A, Figure 3 ). The gene-set analysis showed a significant association of the "ribonucleoprotein complex" GO term with ADHD across the lifespan (P.adj=0.021)
( Supplementary Table 3C [in excel]).
The four loci identified in the single variant analysis had also reached genome-wide significance in the previous GWAS-MA on ADHD by Demontis and Walters et al. 6 , and showed consistent direction of the effect between the two studies ( Supplementary Table 7A ). Genome-wide significant hits reported by Demontis and Walters et al. 6 also showed the same direction of the effect in our data ( Supplementary Table 7B and 7C).
Analyses conditioning on the index variant for the four ADHD-associated loci did not reveal new independent markers associated with ADHD. For each variant within the Bayesian credible sets obtained for these four loci, we searched for expression quantitative trait loci (eQTL) using data from blood 41 and from a meta-analysis across different brain regions 42 . After integrating this information, credible sets for three of the four loci contained at least one eQTL within 1Mb of the index variant. The credible set on chromosome 6 included the index variant (rs183882582) and
rs12197454. This variant, in LD with the index variant (r 2 =0.56), was associated with the expression of RSPH3 in blood and brain (P.adj<1.65E-05 and P.adj=2.36E-07, respectively) and with the expression of VIL2 in blood (P.adj=3.21E-03). The credible set for the second most associated locus on chromosome 7 included 24 variants. The index variant, rs3958046, as well as additional variants in this credible set, were eQTLs for CADPS2 in brain (maximum P.adj=2.91E-03). The credible set for the locus on chromosome 4 contained 50 variants, most of them located in or near PCDH7, but no eQTLs were identified. In the credible set for the locus on chromosome 3, which included 98 variants, the index variant, rs1920644, was associated with the expression of KPNA4, IFT80, and KRT8P12 in brain (P.adj=1.16E-04, P.adj=1.40E-03, and P.adj=1.77E-03, respectively). Many other variants in this credible set were eQTLs for these genes and also for TRIM59, OTOL1, and/or C3orf80 in brain (P.adj<0.05) ( Supplementary Table   8 [in excel]).
In a summary-data-based Mendelian Randomization (SMR) analysis, we used summary data from the GWAS-MA of ADHD across the lifespan and the eQTL data in blood and brain from Westra et al. 41 and Qi et al. 42 to identify gene expression levels associated with ADHD. We found a significant association between ADHD across the lifespan and RMI1 expression in blood after Bonferroni correction (PSMR=5.36E-06) ( Supplementary Table 9 [in excel]). Results from the HEIDI test indicated that this finding was not an artifact due to linkage disequilibrium between eQTL and other ADHD associated variants (PHEIDI=0.60).
Genetic correlation with other ADHD datasets and phenotypes
We found significant genetic correlations of ADHD in children and adults from the previous GWAS-MA 6 (N=53,296) with persistent ADHD (rg=0.85, SE=0.04, P=5.49E-99), ADHD in childhood (rg=0.99, SE=0.03, P=5.02E-273), and ADHD across the lifespan (rg=0.98, SE=0.01, P<2.23E-308) ( Supplementary Table 10 ). When we excluded sample overlap and considered the subset of new samples in our GWAS-MA on ADHD across the lifespan that were not included in the previous GWAS-MA by Demontis and Walters et al. 6 (N=7,086), a significant genetic correlation was also obtained (rg=0.91, SE=0.35, P=8.70E-03).
We also observed significant genetic correlations between childhood ADHD symptom scores from a GWAS-MA in a population of children reported by the EAGLE consortium 43 Table 10 ).
We estimated the genetic correlation of persistent ADHD in adults, ADHD in childhood, and ADHD across the lifespan with all available phenotypes in LD-hub 44 , including ADHD-related traits and other psychiatric and neurological disorders. In total, results for 139 phenotypes passed the quality control parameters (h 2 >0.1 and z-score>4) and 41 genetic correlations were significant after Bonferroni correction in both children and adults with persistent ADHD ( Supplementary   Table 11 [in excel]). The genetic correlations with ADHD were consistent across the lifespan, with similar patterns found in adulthood and childhood (Pearson's r=0.89) ( Figure 4A , Supplementary   Table 11 [in excel]). The phenotypes showing the strongest genetic correlations with ADHD were traits related to academic performance, intelligence and risk-taking behaviors, including smoking and early pregnancy ( Figure 4B) .
Discussion
In the current study, we set out to explore the contribution of common genetic variants to the risk of ADHD across the lifespan. Using the largest GWAS datasets available from the Psychiatric Genomics Consortium (PGC), the Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), and the International Multi-centre persistent ADHD CollaboraTion (IMpACT) consortia, we found evidence for a common genetic basis for ADHD in childhood and ADHD in adults that meet DSM-IV/ICD-10 criteria. We report a high genetic correlation between childhood and persistent ADHD in adulthood, and identified nine novel genome-wide significant loci associated with the disorder in single-variant and/or gene-based analyses.
We found a highly similar proportion of the heritability of ADHD explained by common variants in children (SNP-h 2 =0.21) and in adults (SNP-h 2 =0.20). This is consistent with the ADHD SNP-h 2 estimate reported in the recent GWAS-MA (SNP-h 2 =0.22) 6 , which mainly (but not exclusively) included children with ADHD. Our finding is in line with multiple studies supporting the stability of ADHD's heritability from childhood to adulthood [3] [4] [5] . The heritability results, together with the 0.81 genetic correlation found between children and adults with ADHD reinforce the hypothesis of the neurodevelopmental nature of persistent ADHD in adults. Consistently, the sign test and the PRS analysis confirmed the extensive overlap of common genetic risk variants for ADHD in childhood and adulthood. In addition, the result of the BUHMBOX analysis supported genetic similarities in ADHD across the lifespan with no evidence of a subset of patients enriched for persistent ADHDassociated alleles within the group of children.
Despite not having identified specific genetic contributions for ADHD in children or persistent ADHD, our results are not inconsistent with evidence suggesting changes in the genetic contribution to ADHD symptoms from childhood into adulthood, as described in previous twin studies in the general population 4, 5, 29, 30 . Our study design and the still limited statistical power of the GWAS-MAs on ADHD may have facilitated the identification of the shared genetic basis rather than specific genetic factors for persistence. In addition, differences between such twin studies and the present study in the origin of the samples (population-based versus clinical) and/or discrepancies between self-and medical reports could also explain the reason for not identifying genetic variants associated specifically with childhood and/or persistent ADHD in our study. In addition, given that Chen et al. 45 and Biederman et al. 46 reported that persistence of ADHD into adulthood indexed stronger familial aggregation of ADHD, we cannot yet discard other types of genetic variation, such as rare mutations or copy number variation, playing a role in the different ADHD trajectories across the lifespan.
We also found strong and significant positive genetic correlations of ADHD ascertained in clinical populations of adults, children or both with other ADHD-related measures from general population samples, including the largest GWAS of self-reported ADHD status from 23andMe participants (N=952,652) and the GWAS-MA of childhood rating scales of ADHD symptoms in the general population 43 . In agreement with previous reports, these data suggest that a clinical diagnosis of ADHD in adults is an extreme expression of continuous heritable traits 6 and that a single question about ever having received an ADHD diagnosis, as in the 23andMe sample, may be informative for molecular genetics studies.
Similar patterns of genetic correlation of ADHD with different somatic disorders and anthropometric, cognitive and educational traits were identified for children and adults with ADHD. These findings were highly similar to those observed in the recent GWAS-MA 6 and further extend the existing hypothesis of a shared genetic architecture underlying ADHD and these traits to a lifespan perspective.
We report 13 gene-and SNP-based associations for childhood and adult ADHD as well as ADHD across the lifespan. Four ADHD-associated loci were previously identified by Demontis and Walters et al. 6 , which was expected due to the sample overlap between the two datasets (42, 609 individuals shared out of the 49,560 in our study). The new loci identified in the present study mainly included genes involved in brain formation and function, such as FEZF1, a candidate for autism spectrum disorder implicated in the formation of the diencephalon 47, 48 , RSPH3, which participates in neuronal migration in embryonic brain 49 , CADPS2, which has been associated with many psychiatric conditions due to its role in monoamine and neurotrophin neurotransmission [50] [51] [52] [53] , AMN, which is involved in the uptake of vitamin B12 54, 55 , essential for brain development, neural myelination, and cognitive function 56 , and FBXL17, which has previously been related to intelligence 57 .
In summary, the present cross-sectional analyses identify new genetic loci associated with ADHD and, more importantly, confirm that persistent ADHD in adults is a neurodevelopmental disorder that shows a high and significant genetic overlap with ADHD in children. Walters et al. 6 were not included in our GWAS-MA due to the distribution of children and adults across the different genotyping waves. Detailed information on each dataset is provided in Supplementary Table 12 and in the Supplementary Material.
Online methods
Sample Description
Genotyping, imputation, and quality control
Genotyping platforms and quality control (QC) filters for each of the 19 ADHD datasets are shown in Supplementary Table 12 ). The European ancestry panels of the 1000 Genomes 
GWAS and meta-analyses
Imputed dosages and logistic regression analysis implemented in PLINK 1.9 were used assuming an additive model 61 . In the case-control studies, sex, the first 10 principal components, and other relevant covariates for each study were included ( Supplementary Table 12 ). Summary statistics from each study were filtered prior to meta-analysis, excluding variants with minor allele frequency (MAF) <0.01 and imputation quality scores (INFO) ≤0.8. Inverse-variance weighted fixed-effects meta-analyses were conducted using METAL 62 , and results were filtered by effective sample size >70% of the total, defined as Neff 63 . After filtering, 7,366,995, 7,465,837 and 7,069,304 SNPs and insertion-deletion variants were included in the GWAS metaanalyses (GWAS-MA) of persistent ADHD, ADHD in childhood, and ADHD across the lifespan, respectively. Genomic inflation factors ( and 1000) and the ratio from LD score regression (the proportion of the inflation in the mean chi 2 that the LD Score regression intercept ascribes to causes other than polygenic heritability) were calculated to check population stratification and technical biases. The genome-wide significance threshold was set at P<5.00E-08 to correct for multiple testing. Independent loci for variants exceeding the genome-wide significance threshold were defined based on clumping using PLINK 1.9. Variants that were 250 kb away from the index variant (variant with smallest P-value in the region), with P-value<0.001 and with an estimated linkage disequilibrium (LD) of r 2 >0.2 with the index variant were assigned to a clump (p1=5.00E-08, p2=0.001, r 2 =0.2, kb=250). Manhattan and Forest plots were generated using the 'qqman' and 'forestplot' R packages (3.4.4 version of R), respectively. The LocusZoom software 64 was used to generate regional association plots considering variants located 500 kb from each index variant. r 2 values between index and secondary variants were estimated based on the European ancestry 1000 Genomes Project Phase 3 reference panel.
Conditional analysis
Conditional analyses for top-signals identified in the GWAS-MA of ADHD across the lifespan (1,000 kb from each index variant position) were performed using the Genome-wide Complex Trait Analysis (GCTA) software 65 
Bayesian credible set analysis
Credible sets of genetic variants that were 99% likely, based on posterior probability, to contain the causal variant, were defined using the method described by Maller et al. 66 
Functional characterization of genome-wide significant loci
Variant annotation integrator from UCSC (https://genome.ucsc.edu/cgi-bin/hgVai) was used to obtain functional annotation based on the Human hg19 genome build (Feb 2009). Credible causal sets of variants defined above were merged with the summary statistics of expression quantitative trait loci (eQTL) data from peripheral blood 41 and with eQTL data from a metaanalysis across different brain regions (Brain-eMeta data from Qi et al. 42 ). In the blood dataset, we used the false discovery rate (FDR) information provided 41 , and in the brain dataset we used the 'stats' R package to estimate the FDR (Benjamini & Hochberg) for variants included in any of the four credible sets. The statistical significance for both datasets was set using a threshold of 1.00E-03 for adjusted P-values. Summary data-based Mendelian Randomization (SMR) 67 was used to test for association between gene expression levels and ADHD using summary statistics from the GWAS-MA of ADHD across lifespan and eQTL summary data from blood and brain datasets 41, 42 . The heterogeneity in dependent instruments test (HEIDI) was used to assess whether the SMR findings were due to pleiotropy or linkage 67 .
SNP-based heritability
The SNP-based heritability (SNP-h 2 ) was estimated by single-trait LD score regression using 
Gene-based and gene-set analyses
MAGMA software was undertaken for gene-based and gene-set association testing using summary data from our GWAS-MAs 70 genes in ADHD across the lifespan) and 10,000 permutations were used for multiple testing correction in the gene-based and gene-set analyses, respectively.
BUHMBOX analysis
The Breaking Up Heterogeneous Mixture Based On cross(X)-locus correlations (BUHMBOX) analysis 71 was used to test whether the genetic correlation between persistent ADHD and ADHD in childhood was driven by subgroup heterogeneity, found when there is a subset of children enriched for persistent ADHD-associated alleles. Subgroup heterogeneity was tested in each childhood dataset considering two different SNP sets from the GWAS-MA of persistent ADHD, with P-value thresholds of P<5.00E-05 (62 LD-independent SNPs) and P<1.00E-03 (710 LDindependent SNPs). LD-independent variants with MAF>0.05 were defined by r 2 >0.1 and a distance between them greater than 10,000 kb. BUHMBOX results were meta-analyzed using the standard weighted sum of z-score approach, where z-scores are weighted by the square root of the effective sample size ( ) 63 . The statistical power was calculated using 1,000 simulations, considering the ADHD children meta-analysis sample size (10,617 ADHD cases and 16,537 controls), the odds ratios and risk allele frequencies from the GWAS-MA of persistent ADHD and assuming 65% of heterogeneity proportion (π). The analyses of the sets of 62 and 710 variants had 98.4% and 100% of statistical power, respectively.
Sign test
The direction of the effect of variants associated with ADHD in childhood was tested in persistent ADHD and vice versa, using strict clumping (r 2 =0.05, kb=500, p2=0.5) and different P-value thresholds (1.00E-07, 5.00E-07, 1.00E-06, 5.00E-06, 1.00E-05, 5.00E-05, 1.00E-04, and 5.00E-04). The concordant direction of effect was evaluated using a one sample test of the proportion with Yates' continuity correction against a null hypothesis of P=0.50 with the 'stats' R package.
Polygenic risk scoring
Non-ambiguous strand, independent SNPs (p1=1, p2=1, r 2 =0.1, kb=250) with Neff>70% were selected from the GWAS-MA of ADHD in childhood at different P-value thresholds (P<0.001, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, and 1) to construct polygenic risk scores (PRSs) that were tested for association with persistent ADHD in each of the nine datasets using PRSice-2 (https://choishingwan.github.io/PRSice/). Best guess genotypes from the persistent ADHD datasets were filtered by excluding variants with MAF<0.01, INFO≤0.8 and missing rate >0.02, and only SNPs present in the childhood ADHD GWAS-MA results and in all the persistent ADHD studies were included in the analysis (N=32,584). Each study used the same covariates as included in the GWAS. Results from the nine PRS analyses at each P-value threshold, as well as results for all quintiles, were combined using the inverse-variance weighted meta-analysis.
Genetic correlation
Cross-trait LD score regression with unconstrained intercept was used to calculate genetic correlations (rg) between pairs of traits, considering HapMap3 LD-scores, markers with INFO≥0.90, and excluding the MHC region (hg19:chr6:25-35M) 68 . Other ADHD datasets 6, 43 and phenotypes from the LD-hub centralized database 44 
Data availability
The full GWAS-MA summary statistics for the three meta-analyses will be available for download in the https://www.med.unc.edu/pgc/results-and-downloads webpage. The full GWAS summary statistics for the 23andMe ADHD data set will be made available through 23andMe to qualified researchers under an agreement with 23andMe that protects the privacy of the 23andMe participants. Please visit research.23andme.com/collaborate/#publication for more information and to apply to access the data. 
